Jupiter Neurosciences (JUNS) Shares Outstanding (2023 - 2025)

Jupiter Neurosciences (JUNS) has reported Shares Outstanding (Entity) for 3 consecutive years, with $34.4 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Shares Outstanding (Entity) rose 4.06% year-over-year to $34.4 million; the TTM figure through Dec 2025 stood at $34.4 million (up 4.06% YoY), while the FY2025 annual figure was $34.4 million, up 4.06% from the prior year.
• Shares Outstanding (Entity) was little changed at $34.4 million in Q4 2025 per JUNS's latest filing, from $34.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $34.8 million in Q2 2025 and bottomed at $26.4 million in Q3 2023.
• Historically, Shares Outstanding (Entity) has averaged $31.0 million across 3 years, with a median of $31.6 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) gained 24.8% — and 2025, when it gained 4.06%.
• Jupiter Neurosciences' Shares Outstanding (Entity) stood at $26.5 million in 2023, then gained by 24.8% to $33.1 million in 2024, then rose by 4.06% to $34.4 million in 2025.
• Business Quant data shows JUNS's Shares Outstanding (Entity) at $34.4 million in Q4 2025, $34.3 million in Q3 2025, and $34.8 million in Q2 2025.